Save the Children welcomes Access to Vaccines Index

Save the Children

Save the Children welcomes¬†the first Access to Vaccines Index as a new catalyst to stimulate action from pharmaceutical companies to improve access to vaccines, with potential for “stimulating change and increasing accountability of the pharmaceutical sector and open[ing] a dialogue among all stakeholders to ensure that vaccine prices are not a barrier to reaching every last child.”¬†In a separate blog post, Kirsten Mathieson, Senior Health Policy & Research Adviser at Save the Children, refers to the Index as a “new tool to transparently measure the efforts of pharmaceutical companies.”

Follow us and engage with us on LinkedIn and Twitter.